info iconCurrently, the share price for Marksans Pharma Ltd. is delayed.

close icon
Marksans Pharma Ltd. Logo

Marksans Pharma Ltd.

₹259.00
NSE
--   ( -- %) 1D



  • Prev. Close
    259.00
  • Upper Circuit
    315.70
  • Lower Circuit
    210.47

Analyst Sentiment For Marksans Pharma Ltd.

Info icon
There seem to be no recommendations on this stock from the analyst universe covered

Returns

Marksans Pharma Ltd.'s Info & Management

Marksans Pharma is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations.
  • Chief Financial Officer
    Mr. Jitendra Sharma
  • Senior Vice President(QC)
    Mr. Sunil K Rane
  • Director(Operations)
    Mr. Vishal Bhargava
  • General Manager(International Business)
    Ms. Ashwini Modak
  • Senior General Manager
    Mr. Vivek Mishra
  • Senior General Manager(Quality)
    Mr. Budhrao Patankar

FAQs on Marksans Pharma Ltd.

What is the share price of Marksans Pharma Ltd.?

Marksans Pharma Ltd. share price is ₹263.90 as of September 6, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Marksans Pharma Ltd.?

The 52-week high and low of Marksans Pharma Ltd. is ₹264.00 and ₹97.50 respectively as of September 6, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Marksans Pharma Ltd.?

The trailing twelve month (TTM) PB ratio of Marksans Pharma Ltd. is 5.77 as of September 8, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Marksans Pharma Ltd.?

The Upper Circuit of Marksans Pharma Ltd. is ₹316. The Lower Circuit of Marksans Pharma Ltd. is ₹210.

What is the ROE of Marksans Pharma Ltd.?

Marksans Pharma Ltd. reported an ROE of 16.47% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Marksans Pharma Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Marksans Pharma Ltd., Promoter held 43.9%, the FII held 18.6%, DII held 3.8% and the public held 33.8% of the total shares.

How to buy Marksans Pharma Ltd. Share?

You can easily buy shares of Marksans Pharma Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Marksans Pharma Ltd.?

The fair value of Marksans Pharma Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer